|
⚲
|
| Keyboard |
| ALS Invest 1 BV
✚
|
|
|---|---|
| CIK # | 0001920501 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001920501] | |
| 4 | [0001920501] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Amylyx Pharmaceuticals Inc | |
| ALS Invest 1 BV |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-07-06 | Sell | 2,307 | $22.42 | 51,723 |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-07-06 | Sell | 18,312 | $19.54 | 357,816 |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-07-06 | Sell | 10,395 | $20.60 | 214,137 |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-07-06 | Sell | 29,595 | $21.32 | 630,965 |
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-11 | Conversion | 4,826,503 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Common Stock
|
2022-01-11 | Conversion | 1,129,386 | ||
|
Amylyx Pharmaceuticals Inc AMLX
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 4,826,503 | $0.00 | |
|
Amylyx Pharmaceuticals Inc AMLX
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 1,129,386 | $0.00 |